Composition
- Active ingredients
- MINOCYCLINE HYDROCHLORIDE EQ 90MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- MINOCYCLINE HYDROCHLORIDE EQ 112.5MG BASE · Capsule, extended releaseNDA201922-004 · Discontinued
- MINOCYCLINE HYDROCHLORIDE EQ 67.5MG BASE · Capsule, extended releaseNDA201922-002 · Discontinued
- MINOCYCLINE HYDROCHLORIDE EQ 135MG BASE · Capsule, extended releaseNDA201922-005 · Discontinued
- MINOCYCLINE HYDROCHLORIDE EQ 90MG BASE · Capsule, extended releaseThis page
- MINOCYCLINE HYDROCHLORIDE EQ 45MG BASE · Capsule, extended releaseNDA201922-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA201922.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ximino
- Active substance
- minocycline hydrochloride
- Route
- Oral
- Dosage form
- Capsule, extended release
- Applicant
- Journey
- Status
- Discontinued
- FDA approval
- 11 Jul 2012
- Application
- NDA201922-003